Massachusetts Financial Services
CRL icon

Massachusetts Financial Services’s Charles River Laboratories CRL Stock Holding History

Massachusetts Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$158M Sell
682,173
-226,677
-25% -$40.4M 0.05% 316
2026
Q1 		$159M Buy
908,850
+24,159
+3% +$4.48M 0.05% 289
2025
Q4 		$176M Buy
+884,691
New +$160M 0.06% 293
2022
Q4 		– Sell
-270,130
Closed -$53.2M – 853
2022
Q3 		$53.2M Sell
270,130
-590,305
-69% -$127M 0.02% 430
2022
Q2 		$184M Sell
860,435
-281,787
-25% -$68.9M 0.06% 259
2022
Q1 		$324M Sell
1,142,222
-149,893
-12% -$46.2M 0.1% 191
2021
Q4 		$487M Sell
1,292,115
-65,131
-5% -$25.3M 0.13% 160
2021
Q3 		$560M Sell
1,357,246
-81,163
-6% -$33.7M 0.16% 145
2021
Q2 		$532M Buy
1,438,409
+59,970
+4% +$20M 0.16% 152
2021
Q1 		$400M Buy
1,378,439
+6,689
+0.5% +$1.86M 0.12% 167
2020
Q4 		$343M Buy
1,371,750
+103,869
+8% +$24.7M 0.11% 179
2020
Q3 		$287M Buy
1,267,881
+409,339
+48% +$85M 0.1% 186
2020
Q2 		$150M Buy
858,542
+269,611
+46% +$43M 0.06% 254
2020
Q1 		$74.3M Buy
588,931
+352,637
+149% +$52.9M 0.04% 314
2019
Q4 		$36.1M Buy
236,294
+7,247
+3% +$1M 0.01% 455
2019
Q3 		$30.3M Buy
229,047
+54,841
+31% +$7.35M 0.01% 472
2019
Q2 		$24.7M Buy
174,206
+16,211
+10% +$2.2M 0.01% 510
2019
Q1 		$22.9M Sell
157,995
-25,959
-14% -$3.41M 0.01% 511
2018
Q4 		$20.8M Sell
183,954
-64,957
-26% -$8.13M 0.01% 497
2018
Q3 		$33.5M Buy
248,911
+46,195
+23% +$5.7M 0.01% 458
2018
Q2 		$22.8M Buy
202,716
+79,619
+65% +$8.61M 0.01% 494
2018
Q1 		$13.1M Buy
+123,097
New +$13.3M 0.01% 576

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Massachusetts Financial Services's CRL Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Charles River Laboratories (CRL) stake by 25% in Q2 2026, selling an estimated $40.4M and leaving 682,173 shares worth $158M. The position accounts for 0.05% of the portfolio, ranked #316.

Massachusetts Financial Services first reported a position in CRL in Q1 2018 and has held it in 22 quarters since. The position peaked at $560M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Massachusetts Financial Services held 682,173 shares of Charles River Laboratories worth $158M as of Q2 2026.
  • Massachusetts Financial Services sold 226,677 Charles River Laboratories shares in Q2 2026, an estimated $40.4M.
  • Charles River Laboratories made up 0.05% of Massachusetts Financial Services's portfolio in Q2 2026, its #316 holding.
  • Massachusetts Financial Services first reported a position in Charles River Laboratories in Q1 2018 and has held it in 22 quarters since.
  • Massachusetts Financial Services's Charles River Laboratories position peaked at $560M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.